Regulatory Capital ImprovementBHF's RBC ratio improved to 420-440%, mostly due to the Mean Reverse Parameter benefit.
Sales PerformanceAnnuity sales were $2.3B and Shield sales were $2.0B, showing positive growth in sales.
Stock ValuationAnalyst's target price implies 26% upside potential, based on a 50/50 blend of whole company sale price and standalone valuation.